On 07 November 2025, C-MER Medical Holdings Limited (Stock Code: 03309) provided a Next Day Disclosure Return detailing updates to its issued shares and treasury shares. The opening balance on 05 November 2025 stood at 1,240,692,870 issued shares (excluding 14,868,000 treasury shares), totaling 1,255,560,870 shares.

According to the document, on 07 November 2025, 220,000 shares were repurchased on-market at an average repurchase price of HKD 1.799 per share, reflecting 0.0177% of the then-issued share capital. Following this transaction, the closing balance was 1,240,472,870 shares in issue (excluding 15,088,000 treasury shares), maintaining the total at 1,255,560,870 shares.

The same filing shows that between 12 July 2024 and 15 May 2025, multiple share repurchases for cancellation were carried out but had not yet been cancelled as at the latest closing balance date. The total number of shares authorized for repurchase under the repurchase mandate granted on 19 May 2025 was 125,556,087 shares. The report specifies that the repurchase on 07 November 2025 amounted to 220,000 shares, with an aggregate price of HKD 395,780, all of which will be held as treasury shares.